Avery M A, Fan P, Karle J M, Bonk J D, Miller R, Goins D K
Department of Medicinal Chemistry, School of Pharmacy, University of Mississippi, University 38677, USA.
J Med Chem. 1996 Apr 26;39(9):1885-97. doi: 10.1021/jm950921y.
Provided by total synthesis, endoperoxides 18, 20, and 22 underwent intramolecular oxymercuration-demercuration leading respectively to formation of an isomeric tetracycle, (1aS, 3S, 5aS, 6R, 8aS, 9R, 12S)-10-deoxo-13-carbaartemisinin (19), (+)-10-deoxo-13-carbaartemisinin (21), and (+)-13-carbaartemisinin (4). Structure assignment to 19 and 21 was based on single-crystal X-ray crystallographic analysis. Tricyclic endoperoxide 20 was converted to methyl and benzyl ethers 23 and 24 and reduced to saturated analog 25 which was also converted to ethers 26 and 27. In vitro antimalarial screening of both tri- and tetracyclic analogs was conducted using the W-2 and D-6 clones of Plasmodium falciparum. Neither target 4 nor 21 displayed substantial antimalarial potency in vitro against P. falciparum, but the diastereomeric peroxide 19 possessed good antimalarial potency in vitro. Tricyclic analogs were uniformly impotent. Iron(II) bromide-promoted rearrangement of 21 gave, in 79% yield, the unique tetracyclic alcohol 35, while 19 provided ring-opened cyclohexanone 41 (39%) along with the tricyclic epoxide 42 (20%). Neither 41 nor 42 possessed in vitro antimalarial activity, suggesting that epoxide-like intermediates are not responsible for the mode of action of this subclass of antimalarials. Rearrangement of 10-deoxoartemisinin (43) with FeBr2 gave a major product (79%) not encountered in the rearrangement of artemisinin that resulted from unraveling of the tetracyclic system cyclohexanone 46. Minor amounts of 1,10-dideoxoartemisinin (49) (8%) were also produced in this reaction.
通过全合成得到的内过氧化物18、20和22进行分子内氧汞化-脱汞反应,分别生成一种异构体四环化合物,即(1aS, 3S, 5aS, 6R, 8aS, 9R, 12S)-10-脱氧-13-碳青蒿素(19)、(+)-10-脱氧-13-碳青蒿素(21)和(+)-13-碳青蒿素(4)。19和21的结构归属基于单晶X射线晶体学分析。三环内过氧化物20被转化为甲基醚和苄基醚23和24,并被还原为饱和类似物25,25也被转化为醚26和27。使用恶性疟原虫的W-2和D-6克隆对三环和四环类似物进行了体外抗疟筛选。目标化合物4和21在体外对恶性疟原虫均未表现出显著的抗疟效力,但非对映异构过氧化物19在体外具有良好的抗疟效力。三环类似物均无活性。21在溴化亚铁促进下重排,以79%的产率得到独特的四环醇35,而19则生成开环环己酮41(39%)以及三环环氧化物42(20%)。41和42在体外均无抗疟活性,这表明环氧样中间体并非此类抗疟药物作用方式的原因。10-脱氧青蒿素(43)与FeBr2重排得到一种主要产物(79%),该产物在青蒿素重排中未出现,是由四环体系环己酮46的拆解产生的。此反应中还生成了少量的1,10-二脱氧青蒿素(49)(8%)。